BNTC·08205P100·UQ·equity·Healthcare - Biotechnology-Activist
BNTC (BENITEC BIOPHARMA INC) is held by 48 institutional investors as of Q4 2025. Largest holders: JANUS HENDERSON GROUP PLC ($39.3M), FRANKLIN RESOURCES INC ($29.6M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($28.6M). Net institutional sentiment: Bullish.
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer